Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01602042 · ClinicalTrials.gov registry record
Adaptive Portable Essential Tremor Monitor
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 20
- Enrollment target
NCT01602042: Completed study, sponsored by Great Lakes NeuroTechnologies.
NCT01602042 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01602042 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to monitor essential tremor (ET) to better prescribe therapy to minimize symptoms and expand care for ET patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-11 |
What the finished NCT01602042 record still lists
NCT01602042 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01602042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01602042 about?
NCT01602042 is a clinical study titled "Adaptive Portable Essential Tremor Monitor". The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to monitor essential tremor (ET) to better prescribe therapy to minimize symptoms and expand care for ET patients.
What is the current status of trial NCT01602042?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01602042?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia